COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,794 Articles (22,527 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 899: Articles 8981-8990  | Next

SARS-CoV-2 Testing Strategies for Outbreak Mitigation in Vaccinated Populations
Kumar, C. K., Balasubramanian, R., Ongarello, S., Carmona, S., Laxminarayan, R.
10.1101/2022.02.04.22270483 — Posted: 2022-02-06
Using Digital Humanities for Understanding COVID-19: Lessons from Digital History about earlier Coronavirus Pandemic
Juric, T.
10.1101/2022.02.02.22270333 — Posted: 2022-02-06
Using multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters from genomic sequencing data
Inward, R. P., Faria, N. R., Parag, K. V.
10.1101/2022.02.04.22270165 — Posted: 2022-02-06
SARS-CoV-2 Omicron symptomatic infections in previously infected or vaccinated South African healthcare workers
Nunes, M., Sibanda, S., Baillie, V., Kwatra, G., Aguas, R., Madhi, S.
10.1101/2022.02.04.22270480 — Posted: 2022-02-06
Impacts of the COVID-19 pandemic on future seasonal influenza epidemic
Felix Garza, Z. C., de Jong, S. P. J., Gibson, J., Han, A. X., van Leeuwen, S., de Vries, R. P., Boons, G.-J., van Hoesel, M., de Haan, K., van Groeningen, L., van Willigen, H. D. G., Wynberg, E., de Bree, G. J. C., Matser, A., van der Hoek, L., Prins, M., Kootstra, N. A., Eggink, D., Nichols, B. E., de Jong, M. D., Russell, C. A.
10.1101/2022.02.05.22270494 — Posted: 2022-02-06 Discussion: Onsite
Emulation of a target trial from observational data to compare effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for early treatment of non-hospitalized patients with COVID-19
Mazzotta, V., Cozzi-Lepri, A., Colavita, F., Lanini, S., Rosati, S., Lalle, E., Mastrorosa, I., Cimaglia, C., Vergori, A., Bevilacqua, N., Lapa, D., Mariano, A., Bettini, A., Agrati, C., Piselli, P., Girardi, E., Castilletti, C., Garbuglia, A. R., Vaia, F., Nicastri, E., Antinori, A.
10.1101/2022.02.04.22270143 — Posted: 2022-02-06
Comparative study of immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines in Belarus
Stoma, I., Korsak, K., Voropaev, E., Osipkina, O., Kovalev, A.
10.1101/2022.02.05.22270499 — Posted: 2022-02-06
The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy.
Hassan, S., Ferrari, B., Rossio, R., la Mura, V., Artoni, A., Gualtierotti, R., Martinelli, I., Nobili, A., Bandera, A., Gori, A., Blasi, F., Monzani, V., Costantino, G., Harari, S., Rosendaal, F. R., Peyvandi, F., the COVID-19 Network working group
10.1101/2022.02.04.22270433 — Posted: 2022-02-06
USA Winter 2021 CoVID-19 Resurgence Post-Christmas Update
Eng, G.
10.1101/2022.02.04.22270491 — Posted: 2022-02-06
Interactions among 17 respiratory pathogens: a cross-sectional study using clinical and community surveillance data
Burstein, R., Althouse, B. M., Adler, A., Akullian, A., Brandstetter, E., Cho, S., Chung, E., Emmanuels, A., Fay, K., Gamboa, L., Han, P., Huden, K., Ilcisin, M., Izzo, M., Jackson, M. L., Kim, A. E., Kimball, L., Lacombe, K., Lee, J., Logue, J. K., Rogers, J., Sibley, T. R., Van Raay, K., Wenger, E., Wolf, C. R., Boeckh, M., Chu, H., Duchin, J., Reider, M., Shendure, J., Starita, L. M., Viboud, C., Bedfor, T., Englund, J. A., Famulare, M., Seattle Flu Study and SCAN Investigators
10.1101/2022.02.04.22270474 — Posted: 2022-02-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).